These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1944720)

  • 1. Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis.
    Chan PC; Tam SC; Robinson JD; Yu L; Ip MS; Chan CY; Cheng IK
    Nephron; 1991; 59(1):100-3. PubMed ID: 1944720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients.
    Krack G; Viglino G; Cavalli PL; Gandolfo C; Magliano G; Cantaluppi A; Peluso F
    Perit Dial Int; 1992; 12(4):359-64. PubMed ID: 1420493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral lecithin improves ultrafiltration in patients on peritoneal dialysis.
    Chan H; Abraham G; Oreopoulos DG
    Perit Dial Int; 1989; 9(3):203-5. PubMed ID: 2488366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylcholine administration in continuous ambulatory peritoneal dialysis (CAPD) patients with reduced ultrafiltration.
    De Vecchi A; Castelnovo C; Guerra L; Scalamogna A
    Perit Dial Int; 1989; 9(3):207-10. PubMed ID: 2488367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of phosphatidylcholine on ultrafiltration and solute transfer in CAPD patients.
    Querques M; Procaccini DA; Pappani A; Strippoli P; Passione A
    ASAIO Trans; 1990; 36(3):M581-3. PubMed ID: 2252756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, placebo-controlled trial of spironolactone for hypokalemia in continuous ambulatory peritoneal dialysis patients.
    Yongsiri S; Thammakumpee J; Prongnamchai S; Tengpraettanakorn P; Chueansuwan R; Tangjaturonrasme S; Dinchuthai P
    Ther Apher Dial; 2015 Feb; 19(1):81-6. PubMed ID: 25196890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal phosphatidylcholine levels in patients on continuous ambulatory peritoneal dialysis do not correlate with adequacy of ultrafiltration.
    Beavis J; Harwood JL; Coles GA; Williams JD
    J Am Soc Nephrol; 1993 Jun; 3(12):1954-60. PubMed ID: 8338928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of peritoneal loss of albumin in the hypoalbuminemia of continuous ambulatory peritoneal dialysis patients: relationship to peritoneal transport of solutes.
    Kagan A; Bar-Khayim Y
    Nephron; 1995; 71(3):314-20. PubMed ID: 8569981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal surface-active material in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Ziegler C; Torchia M; Grahame GR; Ferguson IA
    Perit Dial Int; 1989; 9(1):47-9. PubMed ID: 2488180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins.
    Kagan A; Bar-Khayim Y; Schafer Z; Fainaru M
    Nephron; 1993; 63(1):32-42. PubMed ID: 8446249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylcholine and peritoneal transport during peritoneal dialysis.
    Di Paolo N; Buoncristiani U; Capotondo L; Gaggiotti E; De Mia M; Rossi P; Sansoni E; Bernini M
    Nephron; 1986; 44(4):365-70. PubMed ID: 3796777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of peritoneal lymph flow in CAPD using different osmotic agents.
    De Paepe M; Matthys D; Lameire N
    Adv Perit Dial; 1989; 5():12-5. PubMed ID: 2577391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.
    Mactier RA; Khanna R; Twardowski Z; Moore H; Nolph KD
    J Clin Invest; 1987 Nov; 80(5):1311-6. PubMed ID: 3680499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acetate dialysate: responsible for decrease in ultrafiltration in continuous ambulatory peritoneal dialysis].
    Faller B; Marichal JF
    Nephrologie; 1984; 5(2):71-6. PubMed ID: 6483075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral neostigmine and lymphatic absorption in a myasthenia gravis patient on continuous ambulatory peritoneal dialysis (CAPD).
    Chan PC; Tam SC; Cheng IK
    Perit Dial Int; 1990; 10(1):93-6. PubMed ID: 2085592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating peritoneal fluid transport in continuous peritoneal dialysis patients: a practical approach.
    Zhe XW; Tian XK; Shan YS; Cheng L; Wang T
    Nephron Clin Pract; 2007; 107(4):c123-7. PubMed ID: 17957122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal ultrafiltration and fluid reabsorption during peritoneal dialysis.
    Lindholm B; Heimbürger O; Waniewski J; Werynski A; Bergström J
    Nephrol Dial Transplant; 1989; 4(9):805-13. PubMed ID: 2516613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peritoneal equilibration test].
    Morduchowicz G; Feldman T; van Dyk DJ; Boner G
    Harefuah; 1990 Mar; 118(6):312-5. PubMed ID: 2347531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.
    Slingeneyer A; Canaud B; Mion C
    Nephron; 1983; 33(2):133-8. PubMed ID: 6835460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.